Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient derived xenografts in vivo

Overexpression or activation of AKT is very well known to control cell growth, survival and gene expression in solid tumors. Oridonin, an inflammatory medical and diterpenoid compound isolated from Rabdosia rubescens, has exhibited various pharmacological and physiological properties, including anti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Song, Mengqiu, Liu, Xuejiao, Liu, Kangdong, Zhao, Ran, Huang, Hai, Shi, Yuanyuan, Zhang, Man, Zhou, Silei, Xie, Hua, Chen, Hanyong, Li, Yin, Zheng, Yan, Wu, Qiong, Liu, Fangfang, Li, Enmin, Bode, Ann M., Dong, Zigang, Lee, Mee-Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6715294/
https://ncbi.nlm.nih.gov/pubmed/29695636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0823
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados